These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 18020309

  • 21. Identification and characterisation of a novel heat shock protein 90 inhibitor ONO4140.
    Eachkoti R, Reddy MV, Lieu YK, Cosenza SC, Reddy EP.
    Eur J Cancer; 2014 Jul; 50(11):1982-92. PubMed ID: 24835034
    [Abstract] [Full Text] [Related]

  • 22. Identification of small molecules that modify the protein folding activity of heat shock protein 70.
    Wisén S, Gestwicki JE.
    Anal Biochem; 2008 Mar 15; 374(2):371-7. PubMed ID: 18191466
    [Abstract] [Full Text] [Related]

  • 23. Interaction of heat-shock protein 90 beta isoform (HSP90 beta) with cellular inhibitor of apoptosis 1 (c-IAP1) is required for cell differentiation.
    Didelot C, Lanneau D, Brunet M, Bouchot A, Cartier J, Jacquel A, Ducoroy P, Cathelin S, Decologne N, Chiosis G, Dubrez-Daloz L, Solary E, Garrido C.
    Cell Death Differ; 2008 May 15; 15(5):859-66. PubMed ID: 18239673
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Heat shock protein 90 regulates development in Dictyostelium discoideum.
    Sawarkar R, Roy N, Rao S, Raman S, Venketesh S, Suguna K, Tatu U.
    J Mol Biol; 2008 Oct 31; 383(1):24-35. PubMed ID: 18718841
    [Abstract] [Full Text] [Related]

  • 26. High-throughput screening for Hsp90 ATPase inhibitors.
    Avila C, Hadden MK, Ma Z, Kornilayev BA, Ye QZ, Blagg BS.
    Bioorg Med Chem Lett; 2006 Jun 01; 16(11):3005-8. PubMed ID: 16530412
    [Abstract] [Full Text] [Related]

  • 27. Synthesis and biological activity of simplified denoviose-coumarins related to novobiocin as potent inhibitors of heat-shock protein 90 (hsp90).
    Radanyi C, Le Bras G, Messaoudi S, Bouclier C, Peyrat JF, Brion JD, Marsaud V, Renoir JM, Alami M.
    Bioorg Med Chem Lett; 2008 Apr 01; 18(7):2495-8. PubMed ID: 18304811
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Development of a high-throughput screening cancer cell-based luciferase refolding assay for identifying Hsp90 inhibitors.
    Sadikot T, Swink M, Eskew JD, Brown D, Zhao H, Kusuma BR, Rajewski RA, Blagg BS, Matts RL, Holzbeierlein JM, Vielhauer GA.
    Assay Drug Dev Technol; 2013 Oct 01; 11(8):478-88. PubMed ID: 24127661
    [Abstract] [Full Text] [Related]

  • 30. Fragment-based identification of Hsp90 inhibitors.
    Barker JJ, Barker O, Boggio R, Chauhan V, Cheng RK, Corden V, Courtney SM, Edwards N, Falque VM, Fusar F, Gardiner M, Hamelin EM, Hesterkamp T, Ichihara O, Jones RS, Mather O, Mercurio C, Minucci S, Montalbetti CA, Müller A, Patel D, Phillips BG, Varasi M, Whittaker M, Winkler D, Yarnold CJ.
    ChemMedChem; 2009 Jun 01; 4(6):963-6. PubMed ID: 19301319
    [Abstract] [Full Text] [Related]

  • 31. Identifying a C-terminal ATP binding sites-based novel Hsp90-Inhibitor in silico: a plausible therapeutic approach in Alzheimer's disease.
    Khalid S, Paul S.
    Med Hypotheses; 2014 Jul 01; 83(1):39-46. PubMed ID: 24785461
    [Abstract] [Full Text] [Related]

  • 32. Heat-shock protein 90 (Hsp90) as a molecular target for therapy of gastrointestinal cancer.
    Moser C, Lang SA, Stoeltzing O.
    Anticancer Res; 2009 Jun 01; 29(6):2031-42. PubMed ID: 19528462
    [Abstract] [Full Text] [Related]

  • 33. Synthesis and evaluation of Hsp90 inhibitors that contain the 1,4-naphthoquinone scaffold.
    Hadden MK, Hill SA, Davenport J, Matts RL, Blagg BS.
    Bioorg Med Chem; 2009 Jan 15; 17(2):634-40. PubMed ID: 19101151
    [Abstract] [Full Text] [Related]

  • 34. Optimizing natural products by biosynthetic engineering: discovery of nonquinone Hsp90 inhibitors.
    Zhang MQ, Gaisser S, Nur-E-Alam M, Sheehan LS, Vousden WA, Gaitatzis N, Peck G, Coates NJ, Moss SJ, Radzom M, Foster TA, Sheridan RM, Gregory MA, Roe SM, Prodromou C, Pearl L, Boyd SM, Wilkinson B, Martin CJ.
    J Med Chem; 2008 Sep 25; 51(18):5494-7. PubMed ID: 18800759
    [Abstract] [Full Text] [Related]

  • 35. Discovery of 5-substituted 2-amino-4-chloro-8-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)-7,8-dihydropteridin-6(5H)-ones as potent and selective Hsp90 inhibitors.
    Li X, Shocron E, Song A, Patel N, Sun CL.
    Bioorg Med Chem Lett; 2009 May 15; 19(10):2860-4. PubMed ID: 19395259
    [Abstract] [Full Text] [Related]

  • 36. Identification of new Hsp90 inhibitors by structure-based virtual screening.
    Hong TJ, Park H, Kim YJ, Jeong JH, Hahn JS.
    Bioorg Med Chem Lett; 2009 Aug 15; 19(16):4839-42. PubMed ID: 19560353
    [Abstract] [Full Text] [Related]

  • 37. Discovery of benzisoxazoles as potent inhibitors of chaperone heat shock protein 90.
    Gopalsamy A, Shi M, Golas J, Vogan E, Jacob J, Johnson M, Lee F, Nilakantan R, Petersen R, Svenson K, Chopra R, Tam MS, Wen Y, Ellingboe J, Arndt K, Boschelli F.
    J Med Chem; 2008 Feb 14; 51(3):373-5. PubMed ID: 18197612
    [Abstract] [Full Text] [Related]

  • 38. Anti-proliferative activity of heat shock protein (Hsp) 90 inhibitors via beta-catenin/TCF7L2 pathway in adult T cell leukemia cells.
    Kurashina R, Ohyashiki JH, Kobayashi C, Hamamura R, Zhang Y, Hirano T, Ohyashiki K.
    Cancer Lett; 2009 Oct 18; 284(1):62-70. PubMed ID: 19464103
    [Abstract] [Full Text] [Related]

  • 39. [Functional significance of heat shock protein 90].
    Cortés-González CC, Ramírez-González V, Ariza AC, Bobadilla NA.
    Rev Invest Clin; 2008 Oct 18; 60(4):311-20. PubMed ID: 18956553
    [Abstract] [Full Text] [Related]

  • 40. The Hsp90 molecular chaperone: an open and shut case for treatment.
    Pearl LH, Prodromou C, Workman P.
    Biochem J; 2008 Mar 15; 410(3):439-53. PubMed ID: 18290764
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.